VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1827227
Sex: F
Age:
State: CA

Vax Date: 06/10/2021
Onset Date: 06/30/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210602; Test Name: PCR test; Test Result: Negative ; Comments: nasal swab; Test Date: 20210616; Test Name: PCR Test; Test Result: Negative ; Comments: nasal swab; Test Date: 20210708; Test Name: PCR test; Test Result: Negative ; Comments: nasal swab; Test Date: 20210714; Test Name: PCR test; Test Result: Negative ; Comments: nasal swab

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: 3 Phantom periods in July. where I have all the premenstral symptoms and get intense mental cramps, but never get my period; 3 Phantom periods in July. where I have all the premenstral symptoms and get intense mental cramps, but never get my period.; My breasts have been swollen and tender for at least 4 weeks....; breasts have been swollen and tender for at least 4 weeks; premenstral symptoms; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 10Jun2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0182) via an unspecified route of administration in the arm right on 08May2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Jun2021, the patient experienced three phantom periods in Jul2021, where the patient had all the premenstral symptoms and got intense menstrual cramps, but never got period. The patient's breasts had been swollen and tender for at least four weeks at the time of this report. No therapeutic measures were taken as a result of event. Since the vaccination, the patient had been tested for COVID-19. On 02Jun2021, the patient underwent polymerase chain reaction (PCR) test for COVID-19 via nasal swab and the result was negative. On 16Jun2021, the patient underwent polymerase chain reaction (PCR) test for COVID-19 via nasal swab and the result was negative. On 08Jul2021, the patient underwent polymerase chain reaction (PCR) test for COVID-19 via nasal swab and the result was negative. On 14Jul2021, the patient underwent polymerase chain reaction (PCR) test for COVID-19 via nasal swab and the result was negative. The clinical outcome of the event three phantom periods where the patient had all the premenstral symptoms and got intense menstrual cramps, but never got period, breasts had been swollen and tender for at least four weeks, was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1827228
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Periods have been horrible; Very upset; This is a spontaneous report from a contactable consumer. An adult female patient in her 40's (as reported) received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown that patient did receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. On 23Jul2021 at 12:00, reporter was food shopping and a lady came up to the reporter because reporter was wearing her Pfizer Mask and abruptly yelled that on an unknown date, patient's periods had been horrible ever since she received the Pfizer vaccine and patient was very upset and then she stormed off and left the store. The reporter had no information just that patient looked in her 40's and short dark hair. The reporter had no other information to give. It was unknown whether any therapeutic measures were taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events periods have been horrible and very upset was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827229
Sex: F
Age:
State:

Vax Date: 07/23/2021
Onset Date: 07/23/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Diarrhea; Nausea; Lightheaded; Anxious; Vomiting; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 23Jul2021at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, allergy to nickel and latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included daily vitamins (unspecified), azithromycin (MANUFACTURER UNKNOWN) and guaifenesin (MUCINEX) for unknown indications from an unknown date and unknown if ongoing. The patient previously took promethazine hydrochloride / dextromethorphan hydrobromide (PROMETHAZINE DM) and amoxicillin / clavulanic acid (AUGMENTIN) for unknown indications on an unknown date and experienced drug allergy. On 23Jul2021 at 16:45, the patient experienced diarrhea, nausea, lightheaded, anxious and vomiting. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, nausea, lightheaded, anxious and vomiting were recovered on unknown date in Jul2021. No follow-up attempts are possible. No further information is expected.

Other Meds: AZITHROMYCIN; MUCINEX

Current Illness:

ID: 1827230
Sex: F
Age:
State:

Vax Date: 07/19/2021
Onset Date: 07/19/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Hot flashes; Sore throat; Nasal drip; Difficulty concentrating; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Jul2021 at 16:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN), all for unknown indications from unknown date and unknown if ongoing. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. On 19Jul2021 at 23:15, the patient experienced hot flashes, sore throat, nasal drip and difficulty concentrating. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events experienced hot flashes, sore throat, nasal drip and difficulty concentrating was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: GABAPENTIN; BUPROPION; SERTRALINE; IBUPROFEN

Current Illness:

ID: 1827231
Sex: F
Age:
State:

Vax Date: 07/29/2021
Onset Date: 07/29/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Chills; Aches; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Jul2021 at 08:45 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Jul2021 at 09:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 29Jul2021 at 21:00, the patient experienced chills, aches and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, aches and headache was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827232
Sex: F
Age:
State: OH

Vax Date: 07/27/2021
Onset Date: 07/28/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Widespread body aches; Irregular menstrual cycles; Heavy menstrual bleeding; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0198) via an unspecified route of administration in the left arm on 27Jul2021 at 10:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient received unspecified concomitant medications. On 28Jul2021, the patient experienced widespread body aches, irregular menstrual cycles and heavy menstrual bleeding. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event widespread body aches, irregular menstrual cycles and heavy menstrual bleeding were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827233
Sex: F
Age:
State:

Vax Date: 06/12/2021
Onset Date:
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Menstrual cycle affected; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Jun2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date in 2021, the patient's menstrual cycle affected. The clinical outcome of the event menstrual cycle affected was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827234
Sex: F
Age:
State: CA

Vax Date: 07/24/2021
Onset Date: 07/28/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Got urticaria after 4 days when got Pfizer vaccination; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the right arm on 24Jul2021 at 16:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received tetanus vaccine (MANUFACTURER UNKNOWN) and experienced allergy to vaccine (reported as allergies to tetanus needles). On 28Jul2021 at 16:30, 4 days after getting the Pfizer vaccination, the patient experienced urticaria. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were taken as a result of the event and included treatment with cetirizine (ZYRTEC). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event urticaria was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827235
Sex: F
Age:
State: TN

Vax Date: 07/01/2021
Onset Date: 07/29/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: I had nerve pain down my left arm; Injection site pain; Face numbness; I also still have a headache that has not gone away 3 days later.; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA6780) via an unspecified route of administration in the left arm on an unknown date in Jul2021 at 19:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included mild cerebral palsy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ethinylestradiol/norgestimate (SPRINTEC) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received cefaclor (CECLOR) for an unknown indication on an unknown date and experienced drug allergy. On 29Jul2021 at 00:00, after first dose, the patient experienced nerve pain down her left arm, injection site pain, face numbness and also still had a headache that had not gone away 3 days later. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if the patient received any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nerve pain down her left arm, injection site pain, face numbness and also still had a headache that had not gone away 3 days later was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: SPRINTEC

Current Illness:

ID: 1827236
Sex: M
Age:
State: VA

Vax Date: 07/01/2021
Onset Date: 07/01/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Extreme headache; Sick; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the right arm on an unknown date in Jul2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included escitalopram oxalate (LEXAPRO) for an unknown indication from an unknown start date and unknown if ongoing. On an unknown date in Jul2021, about 10 mins after receiving the first dose, the patient experienced extreme headache. It was making the patient sick and was right behind the ears and the patient had never had a headache here before and that bad. The event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme headache and sick was not recovered at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds: LEXAPRO

Current Illness:

ID: 1827237
Sex: F
Age:
State: VA

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Occasionally, joint swelling occurs with the pain.; Moderate to severe full-body joint pain for 24 hours, followed by long term, followed by long term, intermittent mild to moderate joint pain, primarily in hands and arms (but can occur in any joint); This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW6198) via an unspecified route of administration in the left arm on 27Feb2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, acid reflux, migraine, hyperacusis and known allergies to penicillin and its relatives. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline hydrochloride (ZOLOFT), for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 28Feb2021 at 18:30, the patient experienced moderate to severe full-body joint pain for 24hours, followed by long term, intermittent mild to moderate joint pain primarily in hands and arms (but can occur in any joint) that persisted till the time of reporting. Occasionally, joint swelling occurred with the pain. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of the events. The clinical outcome of the event moderate to severe full-body joint pain for 24hours, followed by long term, intermittent mild to moderate joint pain primarily in hands and arms (but can occur in any joint), occasionally, joint swelling occurred with the pain was resolved with sequelae on unknown date in 2021. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 22Mar2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation.

Other Meds: ZOLOFT

Current Illness:

ID: 1827238
Sex: F
Age:
State: FL

Vax Date: 04/14/2021
Onset Date: 05/01/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Name: MRI; Result Unstructured Data: Test Result:Unknown result

Allergies:

Symptom List: Rash, Urticaria

Symptoms: my right knee that caused excruciating pain, extreme swelling; My right knee that caused excruciating pain/shoulder area started hurting; left shoulder/neck area started hurting.; This is spontaneous report from a contactable consumer (patient herself). A 65-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- 8731) via an unspecified route of administration in left arm on 14Apr2021 13:00 as dose 2, single (at the age of 65-years-old) for COVID-19 immunization. Vaccination facility type was reported as Pharmacy/Drug store. The patient was not pregnant at time of vaccination. The patient had no COVID prior vaccination, was not COVID tested post vaccination. The patient took no other vaccine in four weeks. Patient medical history included sinus issues, allergies to penicillin. The concomitant medications included amlodipine besylate, pramipexole, estradiol patch all taken for an unspecified indication, start and stop date were not reported. Historical vaccine included BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: 6955) via an unspecified route of administration in left arm on 24Mar2021 at 14:45 as dose 1, single for COVID-19 immunization. The patient stated that an arthritic attack in her right knee that caused excruciating pain, extreme swelling on 01May2021. She never had knee pain before nor any arthritis. About a month later her left shoulder/neck area started hurting on 01May2021 (as reported). Was not sure what that was and still it hurted. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Patient was treated for the adverse events were treated with MRI, 4 weeks PT, steroid shot in knee. The patient underwent lab test and procedure which included MRI with unknown result on an unspecified date. The outcome of the events resolved with sequel on an unspecified date in 2021. No follow-up attempts are possible. No further information is expected. Follow-up attempts are completed. No further information is expected.

Other Meds: AMLODIPINE BESYLATE; PRAMIPEXOLE; ESTRADIOL

Current Illness:

ID: 1827239
Sex: F
Age:
State: TN

Vax Date: 08/01/2021
Onset Date: 08/02/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Swollen face; Sudden fever; Dizziness; Chest pain; Difficulty breathing deep; Coughing when breathing deep; Overly emotional; All around feeling ill; Tired/sleeping a lot; Tired/sleeping a lot; Severe arm pain; Legs feeling heavy/throbbing; Legs feeling heavy/throbbing; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Aug2021 at 14:30 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Jul2021 at 14:30 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. On 02Aug2021 at 09:15, the patient experienced swollen face, sudden fever, dizziness, chest pain, difficulty breathing deep, coughing when breathing deep, overly emotional, all around feeling ill, tired/sleeping a lot, severe arm pain and legs feeling heavy/throbbing. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with diphenhydramine hydrochloride (BENADRYL) and paracetamol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen face, sudden fever, dizziness, chest pain, difficulty breathing deep, coughing when breathing deep, overly emotional, all around feeling ill, tired/sleeping a lot, severe arm pain and legs feeling heavy/throbbing was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827240
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Worsening joint pain in hands and feet joints; This is a spontaneous report from a non-contactable consumer (patient). A 27-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot number was not reported) via an unspecified route of administration on an unspecified date (age at the time of vaccination 27-year-old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient was not pregnant at the time of vaccination. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date (age at the time of vaccination 27-year-old) as dose 1, single for COVID-19 immunization and experienced moderate nausea. The patient was not diagnosed with COVID prior to vaccination. On an unspecified date, the patient experienced worsening joint pain in hands and feet joints. A day after the first one, moderate nausea that lasted for like 2 days. After the second one within 24 hrs, worsening joint pain in hands and feet joints. The outcome of the event was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827241
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Very heavy period; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced very heavy period. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very heavy period was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827242
Sex: F
Age:
State: CT

Vax Date: 07/06/2021
Onset Date: 07/07/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: I was vomiting from 1am-5am the night after vaccination; I had diarrhea, after every vomit; I would feel immediately better but then shook uncontrollably; Then I did not have any appetite for 3 or 4 days after; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an unspecified route of administration in the left arm on 06Jul2021 at 14:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient previously took brompheniramine; pseudoephedrine (DIMETAPP) and doxycycline (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was vomiting from 01:00 to 05:00, the night after vaccination on 07Jul2021. The patient had diarrhea, after every vomit and would feel immediately better but then shook uncontrollably. Then she did not have any appetite for 3 or 4 days after. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events was vomiting from 01:00 to 05:00, the night after vaccination was resolved on 07Jul2021 at 05:00, while that of had diarrhea, after every vomit and would feel immediately better but then shook uncontrollably, then did not have any appetite for 3 or 4 days after was resolved on an unknown date in Jul2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827243
Sex: F
Age:
State: NH

Vax Date: 05/02/2021
Onset Date:
Rec V Date: 10/29/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210729; Test Name: COVID-19; Result Unstructured Data: Test Result:UNKNOWN RESULTS; Comments: Nasal swab; Test Date: 20210609; Test Name: COVID-19; Test Result: Negative ; Comments: Nasal swab; Test Date: 20210413; Test Name: COVID-19; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Possible extreme and chronic fatigue arising a few weeks after second dose; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW1050) via an unspecified route of administration in the left arm on 02May2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to sulfa and unspecified medical history, which the patient declined to provide. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient received any medication within two weeks of vaccination. It was unknown whether the patient received any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 07Apr2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation and received erythromycin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On an unknown date in 2021, a few weeks after second dose of Pfizer COVID vaccine, the patient experienced possible extreme and chronic fatigue. On 13Apr2021 and 09Jun2021, the patient underwent COVID-19 test via nasal swab and the result was negative. On 29Jul2021, the patient underwent COVID-19 test via nasal swab and the result was unknown. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event extreme and chronic fatigue arising a few weeks after second dose was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1827244
Sex: F
Age:
State: CA

Vax Date: 03/22/2021
Onset Date: 04/10/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210518; Test Name: Nasal Swab; Test Result: Negative.

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: My periods have become unpredictable, more painful; Experiencing new symptoms with my period like breast pain; My periods have come 7-10 days early 3 times, and right now I'm 4 days late; My periods have come 7-10 days early 3 times, and right now I'm 4 days late; I am spotting and cramping between my periods as well; I am spotting and cramping between my periods as well; Periods are lasting longer it used to be 5 days long, now its 8-9 days long; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8730) via an unspecified route of administration in left arm on 22Mar2021 at 10:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation and also the patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0153) via an unspecified route of administration in the left arm on 12Apr2021 at 10:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, liver adenoma and known allergies to shrimp. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received tetracycline (MANUFACTURER UNKNOWN) and experienced drug allergy. On 10Apr2021, the patient experienced that her periods had become unpredictable, more painful, last longer, experienced new symptoms with period like breast pain. Her periods had come 7-10 days early 3 times, and right now she was 4 days late. Periods were lasting longer it used to be 5 days long, now it's 8-9 days long. She was spotting and cramping between her periods as well. It was reported that before the vaccine she was very regular. The events resulted in doctor or other healthcare professional office/clinic visit. On 18May2021, the patient underwent nasal swab test and the result was found to be negative. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events ''my periods have become unpredictable, more painful''; ''experiencing new symptoms with my period like breast pain''; ''my periods have come 7-10 days early 3 times, and right now I'm 4 days late''; ''I am spotting and cramping between my periods as well''; and ''periods are lasting longer it used to be 5 days long, now its 8-9 days long'' was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1827245
Sex: F
Age:
State: IN

Vax Date: 08/03/2021
Onset Date: 08/03/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Fairly severe right leg pain while walking; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the right arm on 03Aug2021 at 17:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an unspecified route of administration in the left arm on 13Jul2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 03Aug2021 at 17:20, about 20 minutes after her second dose, the patient experienced fairly severe right leg pain while walking. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the event. The clinical outcome of the event fairly severe right leg pain while walking was unknown at the time of the report.

Other Meds:

Current Illness:

ID: 1827246
Sex: F
Age:
State: NC

Vax Date: 07/30/2021
Onset Date: 08/03/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Heavy and long periods of vaginal bleeding; This is a spontaneous report from a contactable nurse, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the right arm on 30Jul2021 at 13:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. On 03Aug2021 at 08:30, the patient experienced heavy and long periods of vaginal bleeding after vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event heavy and long periods of vaginal bleeding was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1827247
Sex: F
Age:
State: OK

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Red rash with bumps; severe itching; Rash mainly on arms, chest, and back; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263) via an unspecified route of administration on 02Feb2021(at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination Concomitant medications were not reported. On 03Feb2021 the patient experienced red rash with bumps, severe itching, rash mainly on arms, chest, and back. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events red rash with bumps, severe itching, rash mainly on arms, chest, and back was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1827248
Sex: F
Age:
State: NC

Vax Date: 07/28/2021
Onset Date: 07/28/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Severe headaches; Diarrhea; Nausea; Tiredness; Feeling unwell; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 28Jul2021 at 08:15 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included bacterial meningitis (when the patient was a teen). The patient previously took amitriptyline hydrochloride (TRIPTIN) (reported as medications containing triptin) and experienced drug allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Jul2021 at 15:00, the patient experienced severe headaches, diarrhea, nausea, tiredness, feeling unwell and chills. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events severe headaches, diarrhea, nausea, tiredness, feeling unwell and chills were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827249
Sex: F
Age:
State: MO

Vax Date: 08/01/2021
Onset Date: 08/01/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Fever; Muscle pain; Body aches; Sweats; Chills; Severe headache; Injection site pain; Entire lymph area on left side (arm pit, outter side of breast) painful to touch; This is a spontaneous report from a contactable other healthcare professional, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 01Aug2021 at 13:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 01Aug2021 at 22:00, the patient had fever, muscle pain, body aches, sweats/chills, severe headache, injection site pain and entire lymph area on left side (arm pit, outter side of breast) painful to touch. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, muscle pain, body aches, sweats, chills, severe headache, injection site pain and entire lymph area on left side (arm pit, outter side of breast) painful to touch was resolving at the time of this report.

Other Meds:

Current Illness:

ID: 1827250
Sex: F
Age:
State:

Vax Date: 05/12/2021
Onset Date: 05/16/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Extra heavy flow at start of mensuration cycle (roughly 2x the normal volume of blood); This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 12May2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 21Apr2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 16May2021, the patient had extra heavy flow at start of mensuration cycle that was roughly two times the normal volume of blood. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event extra heavy flow at start of mensuration cycle that was roughly two times the normal volume of blood was resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827251
Sex: F
Age:
State: VA

Vax Date: 08/02/2021
Onset Date: 08/02/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: I was extremely tired where I could fall asleep anywhere; Right arm at injection site sore and sensitive; Right arm at injection site sore and sensitive; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the right arm on 02Aug2021 at 10:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified store-bought allergy medicine and birth control; both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 02Aug2021 at 17:00, after getting the first dose, the patient experienced extremely tired where the patient could fall asleep anywhere and right arm at injection site was sore and sensitive. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely tired where the patient could fall asleep anywhere and right arm at injection site sore and sensitive was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827252
Sex: F
Age:
State: IN

Vax Date: 07/08/2021
Onset Date: 07/26/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Missed period; This is a spontaneous report from a contactable other healthcare professional, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GW0180) via an unspecified route of administration in the left arm on 08Jul2021 at 09:15 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levocetirizine dihydrochloride (XYZAL) for an unknown indication on an unknown date and unknown if ongoing. The patient previously received spironolactone (MANUFACTURER UNKNOWN) and experienced drug allergy on an unknown date. On 26Jul2021, after the first shot, the patient missed period. The shot was received 10 days after the completion of period. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event missed period was unknown at the time of this report.

Other Meds: XYZAL

Current Illness:

ID: 1827253
Sex: F
Age:
State:

Vax Date: 08/05/2021
Onset Date: 08/05/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Severe Migraine; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Aug2021 at 14:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included lupus and known allergies to peanuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol/ diphenhydramine hydrochloride (TYLENOL PM), for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 05Aug2021 at 17:30, the patient experienced severe migraine. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event severe migraine was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: TYLENOL PM

Current Illness:

ID: 1827254
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: My menstrual cycle was disrupted. My period usually lasts 5-7 days. My periods were for two days for two cycles with no pain.; This cycle has been 9 days with heavier bleeding and more pain; This cycle has been 9 days with heavier bleeding and more pain; Had muscle and body pain with breast tenderness; Had muscle and body pain with breast tenderness; Had muscle and body pain with breast tenderness; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date of 2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any concomitant medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On an unknown date in 2021, the patient's menstrual cycle was disrupted and her period usually lasted five to seven days. The patient's periods were for two days for two cycles with no pain. This cycle had been 9 days with heavier bleeding and more pain. The patient had muscle and body pain with breast tenderness since the second vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events menstrual cycle was disrupted and her period usually lasted 5-7 days, periods were for two days for two cycles with no pain, this cycle had been 9 days with heavier bleeding and more pain, had muscle and body pain with breast tenderness was not resolved at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827255
Sex: M
Age:
State: FL

Vax Date: 08/03/2021
Onset Date: 08/04/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Moderate pain near injection site; Moderate to severe pain and swelling in armpit nearest to injection site.; Moderate to severe pain and swelling in armpit nearest to injection site.; Mild rash on chest nearest to injection site; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 03Aug2021 at 18:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease, gastrooesophageal reflux disease (GERD), anxiety, hypogonadism, and COVID-19. The patient had known allergies to gluten. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had received other medications (unspecified) within two weeks of vaccination. On 04Aug2021 at 04:30, the patient experienced moderate pain near injection site, moderate to severe pain and swelling in armpit nearest to injection site and mild rash on chest nearest to injection site. The events did not result in doctor or other health care professional office or clinic visit and emergency room department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events moderate pain near injection site, moderate to severe pain and swelling in armpit nearest to injection site and mild rash on chest nearest to injection site was not resolved at the time of the report.

Other Meds:

Current Illness:

ID: 1827256
Sex: F
Age:
State: NC

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Started menstrual cycle less than 24 hours after receiving vaccine; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Feb2021 at 16:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included pantoprazole sodium sesquihydrate (PROTONIX), zonisamide (MANUFACTURER UNKNOWN), folic acid (MANUFACTURER UNKNOWN) and ethinylestradiol, levonorgestrel (SEASONIQUE); all from an unknown date for unknown indication and unknown if ongoing. The patient previously took salicylic acid (MANUFACTURER UNKNOWN) and bupropion hydrochloride (WELLBUTRIN) for an unknown indication on an unknown date and experienced drug allergy. On 27Feb2021 at 06:00, the patient started menstrual cycle less than 24 hours after receiving vaccine, have not had menstrual cycle in 6 years due to birth control medication. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event started menstrual cycle less than 24 hours after receiving vaccine was resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]; ZONISAMIDE; FOLIC ACID; SEASONIQUE

Current Illness:

ID: 1827257
Sex: F
Age:
State: TN

Vax Date: 07/31/2021
Onset Date: 07/31/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210806; Test Name: Quickvue; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Injection site pain

Symptoms: Headache; Severe abdomen pain; Sternum swollen; Nausea; Hard to take deep breathe; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0171) via an unspecified route of administration in the left arm on 31Jul2021 at 09:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, high cholesterol, anxiety and attention deficit disorder (add) and unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 31Jul2021 at 19:00, the patient experienced headache still as of 07Aug2021, severe abdomen pain, sternum swollen, nausea and hard to take deep breathe. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 06Aug2021, the patient underwent Quickvue via nasal swab and the result was negative. The clinical outcome of the events headache, severe abdomen pain, sternum swollen, nausea and hard to take deep breathe was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1827258
Sex: F
Age:
State:

Vax Date: 07/29/2021
Onset Date: 07/30/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Initiation of an irregular menstrual cycle exactly 24 hours after receiving the vaccine; This is a spontaneous report from a non-contactable physician, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 29Jul2021 at 14:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Jul2021 at 14:00, exactly 24 hours after receiving the vaccine, the patient experienced initiation of an irregular menstrual cycle. The patient took birth control and did not have natural periods but started an irregular bleeding cycle after the first shot. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event initiation of an irregular menstrual cycle exactly 24 hours after receiving the vaccine was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827259
Sex: M
Age:
State: TX

Vax Date: 08/05/2021
Onset Date: 08/09/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Swollen lymph node left arm; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 05Aug2021 at 09:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 09Aug2021 at 06:00, the patient experienced swollen lymph node left arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the event. The clinical outcome of the event swollen lymph node left arm was not resolved at the time of the report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827260
Sex: F
Age:
State: MO

Vax Date: 08/05/2021
Onset Date: 08/05/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Pain (a lot more than other vaccines) at injection site; Moderate to severe soreness in arm; Numbness/tingling in arm up to 4 h after injection; Numbness/tingling in arm up to 4 h after injection; Limited arm mobility; Bruising at injection site (bruising still visible after 5 days); This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Aug2021 at 15:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included eczema. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's any other medications within two weeks was reported as not applicable. On 05Aug2021 at 15:00, the patient experienced pain (a lot more than other vaccines) at injection site, moderate to severe soreness in the arm, numbness/tingling in the arm up to 4 hours after injection, limited arm mobility and bruising at the injection site (bruising was still visible after 5 days). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events numbness/tingling in arm up to 4 h after injection was resolved on 05Aug2021 at 19:00. The clinical outcome of the events pain (a lot more than other vaccines) at injection site, moderate to severe soreness in arm, limited arm mobility was resolved on an unknown date in Aug2021. The clinical outcome of the event bruising at injection site (bruising was still visible after 5 days) was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827261
Sex: F
Age:
State: WI

Vax Date: 08/09/2021
Onset Date: 08/10/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Left arm is sore; Difficulty raising arm; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 09Aug2021 at 17:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, pneumonia, sinusitis and liver disorder (reported as liver psoriasis). It was unknown whether the patient had any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: FC6780) via an unspecified route of administration in left arm on 19Jul2021 at 17:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 10Aug2021 at 00:00, the patients left arm was sore, she had difficulty raising arm and diarrhea after midnight. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event left arm was sore, difficulty raising arm and diarrhea was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827262
Sex: F
Age:
State: TX

Vax Date: 04/30/2021
Onset Date: 05/01/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Pain in L shoulder; Weakness; Nerve pain; Numbness; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 30Apr2021 at 15:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 01Apr2021 at 15:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On an unknown date in May2021, the patient experienced pain in L shoulder, weakness, nerve pain, numbness. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of events. The clinical outcome of the events pain in L shoulder, weakness, nerve pain, numbness was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827263
Sex: F
Age:
State: TN

Vax Date: 08/02/2021
Onset Date: 08/02/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Four hours after receiving vaccine, patient began to feel faint; Went to the bathroom and had onset of extremely heavy vaginal bleeding; Not consistent with the timing of cycle, 1 1/2 week early menstrual cycle, lasting 9 days and usually it only last 4-5 days; Menstrual cycle lasting 9 days and usually it only last 4-5 days; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 02Aug2021 at 10:30(at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified probiotic capsules from wholefoods for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 02Aug2021 at 14:30, 4 hours after receiving vaccine, the patient began to feel faint, went to the bathroom and had onset of extremely heavy vaginal bleeding and was not consistent with the timing of cycle. 1 1/2 week early menstrual cycle which lasted 9 days and usually it only last 4-5 days. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events began to feel faint, went to the bathroom and had onset of extremely heavy vaginal bleeding and was not consistent with the timing of cycle, 1 1/2 week early menstrual cycle which lasted 9 days and usually it only last 4-5 days was resolved on an unknown date in Aug2021.

Other Meds:

Current Illness:

ID: 1827264
Sex: F
Age:
State: NC

Vax Date: 07/12/2021
Onset Date: 07/19/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Menstrual cycle was early by two weeks; Menstrual cycle was heavier than normal.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 12Jul2021 at 17:30 (at the age of 49-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 02Aug2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 19Jul2021, the patient reported that her menstrual cycle was early by two weeks and was heavier than normal. The patient was on that new schedule at the time of reporting even after the second dose on 02Aug2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events menstrual cycle was early by two weeks and was heavier than normal was unknown at the time of this report.

Other Meds:

Current Illness:

ID: 1827265
Sex: F
Age:
State: AZ

Vax Date: 03/05/2021
Onset Date: 03/01/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Antibody test; Result Unstructured Data: Test Result:No/ Undetectable antibodies; Comments: I had the antibody test done by my transplant team; Test Name: Blood test; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Next monthly menstrual cycle was extremely heavy with clots and has continued since that second vaccine So, March 2021 to this date the cycle have been horrible.; This is a spontaneous report from a contactable other healthcare professional. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN06205) via an unspecified route of administration in the arm left on 05Mar2021 at 16:00 (at the age of 46-year-old) and the patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on an unknown date in 2021, as a single dose for COVID-19 immunisation. Medical history included kidney transplant. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included immunosuppressants (MANUFACTURER UNKNOWN), from an unknown date for kidney transplant and unknown if ongoing. On an unknown date in Mar2021, the patient experienced next monthly menstrual cycle was extremely heavy with clots and had continued since that second vaccine So, March 2021 to this date the cycle had been horrible. On an unknown date, the patient underwent SARS CoV-2 test (blood test) and the result was unknown. On an unknown date, the patient underwent antibody test and the result was no/undetectable antibodies. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event, menstrual cycle was extremely heavy with clots and had continued since that second vaccine was unknown at the time of the report.

Other Meds:

Current Illness:

ID: 1827266
Sex: M
Age:
State: UT

Vax Date: 08/09/2021
Onset Date: 08/09/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Painful earache; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Aug2021 at 11:30 (at the age of 64-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 09Aug2021 at 19:00, the patient experienced painful earache. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event painful earache was not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1827267
Sex: F
Age:
State:

Vax Date: 08/10/2021
Onset Date: 08/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: This is a spontaneous report from a non-contactable nurse, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Aug2021 at 15:30 (at the age of 40-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included unspecified beta blocker medications for unspecified indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 11Aug2021 at 01:00, the patient experienced severe joint pain in injection arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of severe joint pain in injection arm and included treatment with unspecified anti-inflammatory medicine from an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe joint pain in injection arm was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827268
Sex: F
Age:
State: GA

Vax Date: 08/07/2021
Onset Date: 08/08/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Severe breast pain; Fever; Chills; Headache; Insomnia; Nausea; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 07Aug2021 at 10:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included fish oil (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and PRENATAL; all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Aug2021 at 21:30, the patient experienced severe breast pain, fever, chills, headache, insomnia, nausea and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of events severe breast pain, fever, chills, headache, insomnia, nausea and dizziness were resolved on an unknown date in Aug2021.

Other Meds: FISH OIL; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1827269
Sex: F
Age:
State: GA

Vax Date: 08/10/2021
Onset Date: 08/11/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Swollen and extremely painful lymphnodes; Swollen and extremely painful lymphnodes; This is a spontaneous report from a contactable other healthcare professional. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the right arm on 10Aug2021 at 14:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included graves' disease. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) from unknown date for unknown indication and unknown if ongoing. On 11Aug2021 at 17:30, the patient experienced swollen and extremely painful lymph nodes. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen and extremely painful lymph nodes was not resolved at the time of this report.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1827270
Sex: M
Age:
State: CA

Vax Date: 08/05/2021
Onset Date: 08/05/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Burning bi-laterally; Severe headache; This is a spontaneous report from a contactable pharmacist. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via intramuscular route of administration in the left arm on 05Aug2021 at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (MOTRIN) over the counter (OTC), taken for an unknown indication from an unknown date and unknown if ongoing. On 05Aug2021 at 12:00, the patient experienced burning bi-laterally and severe headache. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events burning bi-laterally and severe headache was not resolved at the time of this report.

Other Meds: MOTRIN [IBUPROFEN]

Current Illness:

ID: 1827271
Sex: F
Age:
State: CA

Vax Date: 06/07/2021
Onset Date: 06/07/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210713; Test Name: SARS-COV2(Covid 19) Molecular Assay, NASA; Test Result: Negative

Allergies:

Symptom List: Vomiting

Symptoms: Since the time of vaccination have experience increasing psin in both the left and right upper arms, across my shoulders which has affected my range of motion. Extreme pain in the mornings; increasing pain in both the left and right upper arms, across my shoulders; increasing pain in both the left and right upper arms, across my shoulders which has affected my range of motion; Extreme pain in the mornings with very limited mobility in upper body.; joint stiffness and tightness; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 07Jun2021 at 13:45 (at the age of 64-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included colecalciferol (D-3) and calcium (MANUFACTURER UNKNOWN) and unspecified multivitamin; all for unspecified indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO183) via an unspecified route of administration in the left arm on 17May2021at 13:00 (at the age of 64-year-old), as a single dose for COVID-19 immunisation. On 07Jun2021 at 14:00, since the time of vaccination, the patient experienced increasing pain in both the left and right upper arms, across shoulders which had affected range of motion, extreme pain in the mornings with very limited mobility in upper body. Tried to treat with heat therapy and Tylenol but little relief. In pain daily to varying degrees, patient also experienced joint stiffness and tightness. Therapeutic measures were taken as a result of the events and included treatment with heat therapy and Tylenol. Since the vaccination, the patient had been tested for COVID-19. On 13Jul2021, the patient underwent lab tests and procedures which included COVID-19 virus test and the result was negative. The clinical outcome of the event increasing pain in both the left and right upper arms, across shoulders which had affected range of motion, extreme pain in the mornings with very limited mobility in upper body and joint stiffness and tightness was not resolved at the time of this report.

Other Meds: D-3; CALCIUM

Current Illness:

ID: 1827272
Sex: F
Age:
State: CA

Vax Date: 08/01/2021
Onset Date: 08/05/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Approximately 5-6 days after the 2nd vaccine dose I have broken out in an itchy skin rash; The breakouts are located in random places (e.g., small clumps on shoulders, individual lumps on stomach, back, hips, inner thighs, arms), but not at the vaccination site.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Aug2021 at 11:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and stupidity. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included thyroid (ARMOUR THYROID), herbs and calcium (MANUFACTURER UNKNOWN) all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Aug2021, approximately 5-6 days after the second vaccine dose, the patient had broken out in an itchy skin rash that she thought may be due to fleas, mosquitos, or bedbugs, however, there was no evidence of any in her home. The breakouts were located in random places (e.g., small clumps on shoulders, individual bumps on stomach, back, hips, inner thighs, arms), but not at the vaccination site. Rash was still active, not recovered at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events the patient had broken out in an itchy skin rash that she thought may be due to fleas, mosquitos, or bedbugs, however, there was no evidence of any in her home; the breakouts were located in random places (e.g., small clumps on shoulders, individual bumps on stomach, back, hips, inner thighs, arms), but not at the vaccination site was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ARMOUR THYROID; CALCIUM

Current Illness:

ID: 1827273
Sex: M
Age:
State: MA

Vax Date: 08/13/2021
Onset Date: 08/13/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Chest pain upper left quadrant; Ringing in ears; Muscle weakness; Cold sweats; Insomnia; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (COMIRNATY; Lot Number: FA7485) via an unspecified route of administration in the left arm on 13Aug2021 at 14:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously took BNT162b2 (COMIRNATY; Lot Number: EW0612) via an unspecified route of administration in the left arm on 21Jul2021 at 14:15 as a single dose for COVID-19 immunisation. On 13Aug2021 at 16:45, the patient experienced chest pain upper left quadrant, ringing in ears, muscle weakness, cold sweats, insomnia, headache and fatigue. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain upper left quadrant, ringing in ears, muscle weakness, cold sweats, insomnia, headache and fatigue was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1827274
Sex: M
Age:
State: TX

Vax Date: 08/11/2021
Onset Date: 08/13/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: On day 2 there is a smell of metal in nose / stuffy; On day 2 there is a smell of metal in nose / stuffy; In day 2 there is a couple inch welp forming close to injection site in right shoulder; This is a spontaneous report from a contactable other healthcare professional, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 11Aug2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 13Aug2021 at 13:15, on day 2 there was a smell of metal in nose/stuffy and there was a couple inch welp forming close to injection site in right shoulder. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events on day 2 there was a smell of metal in nose/stuffy and in day 2 there was a couple inch welp forming close to injection site in right shoulder was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827275
Sex: F
Age:
State:

Vax Date: 08/12/2021
Onset Date: 08/13/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210811; Test Name: COVID-19 test; Test Result: Negative ; Comments: Abbot

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Fever; Chills; Body aches; Headache; Neck pain; Weakness; Loss of appetite; This is a spontaneous report from a non-contactable nurse, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Aug2021 at 17:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and known allergies to penicillin. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Jul2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 11Aug2021, the patient underwent COVID-19 test and the result was negative. On 13Aug2021 at 06:00, the patient experienced fever, chills, body aches, headache, neck pain, weakness and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events fever, chills, body aches, headache, neck pain, weakness and loss of appetite was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1827276
Sex: F
Age:
State:

Vax Date: 08/02/2021
Onset Date: 08/02/2021
Rec V Date: 10/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: The third day the jaw pain; Slept all day the second day; Tiredness the day of the shots; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 02Aug2021 at 11:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), for unknown indication from an unknown date and experienced drug allergy. On 02Aug2021, the patient experienced tiredness the day of the shots, slept all day the second day (on 03Aug2021) and the third day (04Aug2021 at 04:00) the jaw pain started up to the moment 15Aug2021. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tiredness the day of the shots, slept all day was unknown while that of the jaw pain started up was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am